Latest papers

High (18)F-FDG uptake by the remaining adrenal gland four months after surgery and initiation of mitotane treatment in two patients with adrenocortical carcinoma.

[Advanced breast cancer in a patient achieving long-term SD after letrozole administration for liver metastasis developing during anastrozole therapy].

A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancer.

[Molecular prognostic and predictive markers of breast cancer treatment].

Molecularly targeted endocrine therapies for breast cancer

Renal cell cancer: state of the art in adjuvant therapy.

A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer.

Growth in children with acute lymphoblastic leukemia during treatment.

Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.

[Adjuvant cancer therapy].

[Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir].

[Managing side effects of androgene deprivation in prostate cancer].

[Adjuvant treatment in hormone receptor positive breast cancer].

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer.

[A case of primary malignant lymphoma of the prostate presenting as urinary retention].

Risk reduction strategies for ductal carcinoma in situ.

[Two cases of pellagra associated with chemotherapy of docetaxel, estramustine, dexamethasone].

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: a randomized, placebo-controlled study.

Response assessment of hormonal therapy in prostate cancer by [11C] choline PET/CT.